Helicobacter pylori and Nonmalignant Diseases
Open Access
- 9 September 2013
- journal article
- review article
- Published by Wiley in Helicobacter
- Vol. 18 (s1) , 24-27
Abstract
Declining Helicobacter pylori prevalence rates have resulted in a decrease of peptic ulcer bleeding incidence. Moreover, eradication reduces peptic ulcer recurrence rate. Newer studies confirm that H. pylori eradication lowers the risk of recurrent peptic ulcer bleeding. Guidelines therefore advocate a test‐and‐treat strategy for patients with a history of ulcer bleeding and NSAIDs and/or aspirin use. There is mounting evidence that H. pylori status has no effect on symptoms and treatment efficacy in patients with gastroesophageal reflux disease (GERD). Some studies observed an improvement of GERD complaints after H. pylori eradication, which underlines that H. pylori treatment is not contra‐indicated in GERD patients. The exact role of H. pylori in functional dyspepsia (FD) remains controversial. However, there is growing consensus that H. pylori‐positive FD should be assessed as a separate entity. In these patients, eradication can be beneficial and appropriate. Finally, several studies suggest that H. pylori infection may also be associated with beneficial effects for the host. Epidemiologic studies showed an inverse relation between H. pylori infection and asthma and allergy, although data are conflicting and need to be expanded.Keywords
This publication has 27 references indexed in Scilit:
- Effects of Helicobacter pylori Infection on Long-term Risk of Peptic Ulcer Bleeding in Low-Dose Aspirin UsersGastroenterology, 2013
- Improvement of reflux symptom related quality of life after Helicobacter pylori eradication therapyJournal of Clinical Biochemistry and Nutrition, 2013
- Long-Term Follow-Up of 1,000 Patients Cured of Helicobacter pylori Infection Following an Episode of Peptic Ulcer BleedingAmerican Journal of Gastroenterology, 2012
- Management of Helicobacter pylori infection—the Maastricht IV/ Florence Consensus ReportGut, 2012
- Effect ofHelicobacter pyloritreatment on gastroesophageal reflux disease (GERD): meta-analysis of randomized controlled trialsScandinavian Journal of Gastroenterology, 2012
- Epidemiology and Demographics of Upper Gastrointestinal Bleeding: Prevalence, Incidence, and MortalityGastrointestinal Endoscopy Clinics of North America, 2011
- The Prevalence and Incidence of Helicobacter pylori–Associated Peptic Ulcer Disease and Upper Gastrointestinal Bleeding Throughout the WorldGastrointestinal Endoscopy Clinics of North America, 2011
- Has H. pylori Prevalence in Bleeding Peptic Ulcer Been Underestimated? A Meta-RegressionAmerican Journal of Gastroenterology, 2011
- Systematic review: the global incidence and prevalence of peptic ulcer diseaseAlimentary Pharmacology & Therapeutics, 2009
- Role of Helicobacter pylori infection and non-steroidal anti-inflammatory drugs in peptic-ulcer disease: a meta-analysisThe Lancet, 2002